NurExone Biologic Inc.
NRXBF
$0.50
$0.011.31%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.97% | 27.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.18% | 14.56% | |||
| Operating Income | -7.18% | -14.56% | |||
| Income Before Tax | -10.01% | -8.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.01% | -8.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.01% | -8.54% | |||
| EBIT | -7.18% | -14.56% | |||
| EBITDA | -7.42% | -12.57% | |||
| EPS Basic | -6.58% | -5.07% | |||
| Normalized Basic EPS | -7.04% | -4.41% | |||
| EPS Diluted | -6.58% | -5.07% | |||
| Normalized Diluted EPS | -7.04% | -4.41% | |||
| Average Basic Shares Outstanding | 3.30% | 3.55% | |||
| Average Diluted Shares Outstanding | 3.30% | 3.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||